AdnexusBiotech

Let’s celebrate #Diwali, a magnificent festival of light and opportunity, glowing with promise like the stars in the night sky! As Adnexus Biotechnologies Inc. marches on this exciting chapter, we sincerely wish you a Diwali filled with prosperity, and boundless success #Sutra

@drgauravchandra @ImKingofPrussia @CBDWInc More information will be available on adnexusbiotech.com and sutraai.ai

@ImKingofPrussia @AdnexusBiotech @CBDWInc Thank you for posting this. Our #AI drug discovery platform, Sutra, incorporates the Bionexus platform's capabilities and a curated eight-million-molecule database. We will unveil its full potential. #CBDW

$CBDW Introducing BioNexus™, an @AdnexusBiotech AI Platform for Early Drug Discovery and Development. The recent partnership announcement between @CBDWInc and #Adnexus aims to capitalize on the companies' strengths in the fields of #ArtificialInteligence and revolutionary, patent-pending medicine. Learn More about Adnexus: adnexusbiotech.com Learn More about 1606 Corp.: cbdw.ai

@drgauravchandra @tonka_waterman As we further develop our AIDD capabilities and HIV drugs through groundbreaking work in our lab at the University of Missouri and global partners, we will provide additional information on our website at adnexusbiotech.com. @drgauravchandra

Correction: #CBDW has taken an equity stake in Adnexus Biotechnologies Inc.Adnexus is an AI Drug Development company specializing in identifying immutable target sites and innovative biomarkers to develop drugs to prevent and treat infectious and neurological diseases. As we diligently build the #AIDD as a revenue-generating platform, we are particularly excited about its potential to advance our assets for HIV with Immunotherapy and chemotherapy. This is a significant step forward in our mission. # Mabs # capsidinhibitor

@AdnexusBiotech @drgauravchandra can you confirm that adnexus was acquired?

We're thrilled about this nonbinding Letter of Intent (LOI) to acquire strategic stake in Adnexus Biotechnologies Inc., acknowledging our revolutionary #AIDD platform. Watch for more updates on our website adnexusbiotech.com #AIDD @drgauravchandra capedge.com/filing/1877461…

Thank you for your patience as we continue to work on our website. It will provide information about #AI Drug Discovery Platform, partners, and our progress. We are currently testing and optimizing it before the official launch. adnexusbiotech.com #AIDD #HIV #Malaria #SARS

There has been a significant increase in the number of published scientific papers and patents. However, there is evidence of a slowdown in groundbreaking research.Embracing more chaos and less order may be necessary for innovation the-yuan.com/887/The-world-… @drgauravchandra #XAI

@drgauravchandra @ylecun @elonmusk @drgauravchandra @YuanCommunity We look forward to this article.

There is an ongoing debate about the link between groundbreaking scientific research and peer review. Despite the publication of over 50 million new scientific papers and five million patents in the last 70 years, there is a slowdown in producing disruptive research since 1945. Research productivity in areas like semiconductors and pharmaceuticals is declining. It has been noted that papers, patents, and grant applications are now less innovative and less likely to connect different areas of knowledge, which are essential for fostering innovation. We focus heavily on established science and confident investments but are reluctant to invest in potentially disruptive new concepts. We need to embrace more chaos and less order—my article, in the Yuan next week.

Join xAI if you believe in our mission of understanding the universe, which requires maximally rigorous pursuit of the truth, without regard to popularity or political correctness

"Heroes never Die. They live on in the hearts and minds of those who would follow in their footsteps" ~ Emily Potter #memorialday #ADNX

“The best way to predict the future is to create it.” – Abraham Lincoln At Adnexus we continue to create a future with focus on helping patients. #HIV #AI #IPportfolio @drgauravchandra #bridgingbiologyandtechnology #AIdrugdiscovery More patents, partnerships and mergers incoming.

Launching adnexusbiotech.com soon showcasing AI Platform #BioNexus with capability to identify biomarkers,In Silico methods,Predictive models complemented with capability to produce and test the #AI identified therapeutic target in lab #Drugdiscovery @drgauravchandra

@Xaira_Thera an innovative #AI-based drug developer launched with a bold vision to transform #DrugDiscovery and development. Focussed on collaborative intelligence, it can create new & effective treatments faster, utilizing the full potential of AI genengnews.com/topics/artific…

Congratulations to our partners Sanctum Therapeutics & Remedium.They used in-silico modular docking & cell-based studies to identify phytoconstituents in herbal supplements that treated SARS-CoV2 &received Indian government approval. #Adnexus #Sanctum #AI #DrugDiscovery #CoroQuil

Adnexus-Bridging Biology and Technology Pioneering Tomorrow's Healthcare Solutions #AI #Adnexus #BioNexus